SCHEMBL25218484

SCHEMBL25218484

O=C(O)c1cn(C2CC2)c2nc(N3CC[C@H](CO)C3)c(F)cc2c1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.64
CHRM2 P08172 1/20 0.58
DRD1 P21728 1/20 0.58
LMNA P02545 3/20 0.55
KDM4E B2RXH2 2/20 0.55
HSD17B10 Q99714 2/20 0.55
ABCC4 O15439 1/20 0.55
KMT2A Q03164 1/20 0.53
CYP2C9 P11712 2/20 0.52
ATP6V1B2 P21281 1/20 0.52
TBXA2R P21731 1/20 0.52
EDNRA P25101 1/20 0.52
TARBP2 Q15633 1/20 0.52
KCNH2 Q12809 1/20 0.51
DHFR P00374 1/20 0.51
ALDH1A1 P00352 1/20 0.48
CYP1A2 P05177 1/20 0.48
TOP2A P11388 1/20 0.48
HPGD P15428 1/20 0.48
TOP2B Q02880 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9734972 1.00 DPP4 (0.64) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL25274064 0.91 DPP4 (0.64) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL9116420 0.91 DPP4 (0.64) DPP4CHRM2DRD1LMNAKDM4E
Hydrochloric Acid SCHEMBL10512529 0.91 DPP4 (0.63) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL9437372 0.91 DPP4 (0.62) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL9457439 0.91 DPP4 (0.62) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL25273735 0.89 DPP4 (0.53) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL30482922 0.89 DPP4 (0.53) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL9437340 0.89 DPP4 (0.58) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL9437323 0.89 DPP4 (0.58) DPP4CHRM2DRD1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250295790-A1 LECTIN-TARGETING CONJUGATES HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2025-09-25 US disclosed
EP-4444355-A2 LECTIN-TARGETING CONJUGATES Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2024-10-16 EP disclosed
WO-2023104922-A2 LECTIN-TARGETING CONJUGATES Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2023-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250295790-A1 LECTIN-TARGETING CONJUGATES MASP2, LGALS3BP, LGALS1 DPP4 161/4885CHRM2 3211/4885DRD1 3822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.